RecruitingNot ApplicableNCT06810713

Evaluation of a Training for Healthcare Providers in Supporting Men Experiencing Suicidal Ideation


Sponsor

University Ghent

Enrollment

120 participants

Start Date

May 27, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The primary objective of this study is to assess how healthcare providers perceive and evaluate the developed e-learning. The findings will inform potential adjustments to enhance the e-learning as needed.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Healthcare providers (e.g. GP's, psychiatrists, medical doctors, psychologists, psychotherapists, and nurses working in healthcare)
  • ≥18y/o
  • Access to a smartphone, tablet, or computer with internet connection and proficiency in Dutch

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALGatekeeper training (e-learning)

This training supplements existing modules for healthcare providers working with individuals experiencing suicidal thoughts (https://sp-reflex.zelfmoord1813.be/e-learning). Specific information on working with men will be added: * Information on suicidality among men and the importance of gender-sensitive care. * Guidance on recognizing signs of suicidality in men and understanding gender differences in suicide-related communication. * Insights into the impact of gender norms and socialization on suicidality and help-seeking behavior in men experiencing suicidal thoughts. * Awareness of providers' own gender biases and the influence of societal gender norms in treating men with suicidal ideation. * Recommendations for engaging men in treatment, with specific guidance on language and approaches for interacting with men who have suicidal thoughts. Additionally, the e-learning will a model psychoeducation about the role of norms for men experiencing suicidal ideation.


Locations(1)

Flemish Centre of Expertise in Suicide Prevention, Ghent University

Ghent, Belgium

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06810713


Related Trials